{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:38:14Z","timestamp":1784140694621,"version":"3.55.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMAR"],"DOI":"10.2147\/cmar.s133291","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T18:01:51Z","timestamp":1522087311000},"page":"615-624","source":"Crossref","is-referenced-by-count":28,"title":["Management of relapsed\/refractory marginal zone lymphoma: focus on ibrutinib"],"prefix":"10.2147","volume":"Volume 10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7936-7547","authenticated-orcid":true,"given":"Nathan M","family":"Denlinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendranath","family":"Epperla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basem M","family":"William","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2018,3]]},"container-title":["Cancer Management and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=41191","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=41191","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T18:01:51Z","timestamp":1522087311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/management-of-relapsedrefractory-marginal-zone-lymphoma-focus-on-ibrut-peer-reviewed-article-CMAR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/cmar.s133291","relation":{},"ISSN":["1179-1322"],"issn-type":[{"value":"1179-1322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}